Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice

被引:219
作者
Aasum, E
Hafstad, AD
Severson, DL
Larsen, TS
机构
[1] Univ Tromso, Inst Med Biol, Dept Med Physiol, Fac Med, N-9037 Tromso, Norway
[2] Univ Calgary, Fac Med, Dept Pharmacol & Therapeut, Calgary, AB T2N 1N4, Canada
关键词
D O I
10.2337/diabetes.52.2.434
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucose and palmitate metabolism and contractile function were measured with ex vivo perfused working hearts from control (db/+) and diabetic (db/db) female mice at 6, 10-12, and 16-18 weeks of age. Palmitate oxidation was increased by 2.2-fold in 6-week-old db/db hearts and remained elevated in 10- to 12- and 16- to 18-week-old hearts. Carbohydrate oxidation was normal at 6 weeks but was reduced to 27 and 23% of control at 10-12 and 16-18 weeks, respectively. At 6 weeks, db/db hearts exhibited a slight reduction in mechanical function, whereas marked signs of dysfunction were evident at 10-12 and 16-18 weeks. Mechanical function after ischemia-reperfusion was examined in hearts from male mice; at 6 weeks, db/db hearts showed normal recovery, whereas at 12 weeks it was markedly reduced. Fatty acid oxidation was the predominant substrate used after reperfusion. Thus, diabetic db/db hearts exhibit signs of a progressive cardiomyopathy; increased fatty acid oxidation preceded reductions in carbohydrate oxidation. Postischemic recovery of function was reduced in db/db hearts, in parallel with age-dependent changes in normoxic contractile performance. Finally, peroxisome proliferator-activated receptor-alpha treatment (3 weeks) did not affect sensitivity to ischemia-reperfusion, even though carbohydrate oxidation was increased and palmitate oxidation was decreased.
引用
收藏
页码:434 / 441
页数:8
相关论文
共 52 条
[11]   DIABETIC CARDIOMYOPATHY [J].
FEIN, FS .
DIABETES CARE, 1990, 13 (11) :1169-1179
[12]   Controversies on the sensitivity of the diabetic heart to ischemic injury: The sensitivity of the diabetic heart to ischemic injury is decreased [J].
Feuvray, D ;
Lopaschuk, GD .
CARDIOVASCULAR RESEARCH, 1997, 34 (01) :113-120
[13]   GLYCOLYSIS AND GLUCOSE-OXIDATION DURING REPERFUSION OF ISCHEMIC HEARTS FROM DIABETIC RATS [J].
GAMBLE, J ;
LOPASCHUK, GD .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1225 (02) :191-199
[14]  
GIACOMELLI F, 1979, LAB INVEST, V40, P460
[15]   GLYCEMIC IMPROVEMENT IN DIABETIC DB/DB MICE BY OVEREXPRESSION OF THE HUMAN INSULIN-REGULATABLE GLUCOSE-TRANSPORTER (GLUT4) [J].
GIBBS, EM ;
STOCK, JL ;
MCCOID, SC ;
STUKENBROK, HA ;
PESSIN, JE ;
STEVENSON, RW ;
MILICI, AJ ;
MCNEISH, JD .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1512-1518
[16]   Diabetes and cardiovascular disease - A statement for healthcare professionals from the American Heart Association [J].
Grundy, SM ;
Benjamin, IJ ;
Burke, GL ;
Chait, A ;
Eckel, RH ;
Howard, BV ;
Mitch, W ;
Smith, SC ;
Sowers, JR .
CIRCULATION, 1999, 100 (10) :1134-1146
[17]   Murine cardiac function - A cautionary tail [J].
Kass, DA ;
Hare, JM ;
Georgakopoulos, D .
CIRCULATION RESEARCH, 1998, 82 (04) :519-522
[18]   Rosiglitazone, a peroxisome proliferator-activated receptor-γ, inhibits the Jun NH2-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury [J].
Khandoudi, N ;
Delerive, P ;
Berrebi-Bertrand, I ;
Buckingham, RE ;
Staels, B ;
Bril, A .
DIABETES, 2002, 51 (05) :1507-1514
[19]   Free fatty acids, but not ketone bodies, protect diabetic rat hearts during low-flow ischemia [J].
King, LM ;
Sidell, RJ ;
Wilding, JR ;
Radda, GK ;
Clarke, K .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (03) :H1173-H1181
[20]  
Komers R, 1998, PHYSIOL RES, V47, P215